83-5593-72 U2OS Cells 1vial 300364

※お見積書はカートで印刷できます

冷凍

特徴

  • 概要:U2OS cells, an osteosarcoma cell line derived from a human osteosarcoma patient, play a significant role in cancer research, particularly in the study of bone cancer.
  • U2OS cells are used extensively in cancer research, drug development, apoptosis studies, genetic research, and radiation oncology studies.
  • The value of U2OS cells lies in their application to investigate apoptosis and drug resistance, essential for creating small molecule inhibitors and similar therapeutic agents.
  • In the realm of clinical osteosarcoma research, the U2OS cell line is instrumental in examining biological responses to radiotherapy, thereby enriching our understanding of osteosarcoma biology.
  • These cells are also pivotal in investigating chromatin modifications and their impact on cell biology, especially in the context of tumor formation and cancer progression.
  • The U2OS cell line, also referred to as the OS cell line, is recognized for its in vivo tumor formation capacity when administered through subcutaneous and intramuscular injections.
  • The tumors produced by U2OS cells are characterized as high-grade sarcomas and exhibit significant osteoid production, which is a hallmark of osteosarcoma.
  • Additionally, these tumors showed infiltration by immune cells.
  • U2OS therefore serves as a representative model for studying human osteosarcoma, its interactions with the human immune system and tumor immunology.
  • One of the challenges, however, is ensuring the osteosarcoma U2OS cell line accurately reflects the tumors in vivo, given the variability in tumor formation capacity.
  • In summary, sarcoma cell lines such as U2OS serve as a pivotal tool in understanding osteosarcoma, offering valuable insights into cancer biology, therapeutic development, and the complexities of tumor-immune system interactions, while highlighting the need for accurate in vivo tumor modeling.

仕様

  • 容量:1vial
  • カテゴリー: Bone cancer cell lines
  • Organism:Human
  • Tissue:Bone, tibia
  • Disease:Osteosarcoma
  • Synonyms:U-2 OS, U-2OS, U-2-OS, U2-OS, U20-S, U20S, 2T
  • Age:15 years
  • Gender:Female
  • Ethnicity:Caucasian
  • Morphology:Epithelial-like
  • Growth Properties:Monolayer, adherent
  • Citation:U-2 OS (Cytion catalog number 300364)
  • Biosafety Level:1
  • Receptors Expressed:Insulin-like growth factor I (IGF-I), insulin-like growth factor II (IGF-I), Osteosarcoma derived growth factor (ODGF)
  • Antigen Expression:Blood Type A, Rh+, HLA A2, Aw30, B12, Bw35, B40(+/-)
  • Isoenzymes:PGM3, 1, PGM1, 2, ES-D, 1, AK-1, 1, GLO-1, 2, G6PD, B, Phenotype Frequency Product: 0.0082
  • Products:Osteosarcoma derived growth factor (ODGF)
  • Karyotype:(P11-46) hypodiploid to near tetraploid, (P111-118) modal numbers 34 to 37 and 64 to 67 with abnormalities including dicentrics, breaks, rings, and pulverizations plus acrocentric subtelocentric and minute markers
  • 非営利団体(アカデミア)様向けの価格です。営利企業様や営利目的での販売は実施しておりません。
  • 購入にはメーカーの「Non Profit Supply Agreement」及び弊社の「ヒト生体試料の提供に関する同意書」への記入が必要となる場合がございます。
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
83-5593-72
型番
300364
入り数
1個
標準価格
-円
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る